What is Diamox Used For?
Diamox (acetazolamide) is a carbonic anhydrase inhibitor used primarily for treating glaucoma, epilepsy, heart failure-related edema, central sleep apnea, and preventing acute mountain sickness. 1
FDA-Approved Indications
According to the FDA drug label, Diamox is indicated for 1:
- Glaucoma management: Chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperative reduction of intraocular pressure in acute angle-closure glaucoma
- Epilepsy: Adjunctive treatment for centrencephalic epilepsies (petit mal, unlocalized seizures)
- Edema: Treatment of edema due to congestive heart failure and drug-induced edema
- Acute mountain sickness (AMS): Prevention or amelioration of symptoms in climbers attempting rapid ascent and those highly susceptible to AMS despite gradual ascent
Mechanism of Action
Acetazolamide inhibits carbonic anhydrase, the enzyme catalyzing the reversible hydration of carbon dioxide and dehydration of carbonic acid 1. This produces several therapeutic effects:
- In the eye: Decreases aqueous humor secretion, lowering intraocular pressure
- In the kidney: Causes renal bicarbonate loss with sodium, water, and potassium excretion, producing diuresis and urinary alkalinization
- In the CNS: Retards abnormal, excessive neuronal discharge in epilepsy
- At altitude: Stimulates respiration and improves oxygenation through metabolic acidosis
Clinical Applications Based on Recent Guidelines
Central Sleep Apnea (2025 AASM Guidelines)
The American Academy of Sleep Medicine conditionally recommends acetazolamide for multiple forms of central sleep apnea 2:
- Primary CSA
- CSA due to heart failure
- CSA due to medication or substance use
- Treatment-emergent CSA
- CSA due to medical conditions
- CSA due to high altitude
Dosing: 250-1,000 mg daily, typically divided doses 2
Evidence shows: Clinically meaningful reductions in apnea-hypopnea index (AHI) and improvements in Epworth Sleepiness Scale scores, though cardiac function improvements were limited 2
Critical monitoring requirement: When used for CSA in heart failure or high altitude, follow-up electrolyte assessment is recommended after 2-4 weeks due to concerns about acid-base disturbances and potential arrhythmias 2
Acute Mountain Sickness Prevention
For rapid ascent above 2,500-3,500 m, acetazolamide 500-750 mg/day is most effective when started within 24 hours of altitude exposure 3. The 2025 AASM guidelines support using 250 mg acetazolamide for 1-2 nights at altitude, showing clinically meaningful improvements in AHI and desaturation index 2.
The 2018 European cardiovascular guidelines note acetazolamide is frequently used for mountain sickness prophylaxis and treatment, though caution is advised when combining with other diuretics due to dehydration and electrolyte imbalance risks 4.
A 2026 phase III trial in Chinese Han adults demonstrated that extended-release acetazolamide 500 mg once daily reduced AMS incidence from 55.9% to 36.9% and moderate/severe AMS from 24.5% to 9.9% 5.
Emerging Clinical Uses
Acute Decompensated Heart Failure
Acetazolamide is gaining recognition as a "chloride-regaining diuretic" for overcoming diuretic resistance in heart failure 6, 7. Under the "chloride theory" of heart failure, acetazolamide increases serum chloride concentration within 10 days, with effects persisting for at least 60 days 7.
Dosing: 250-500 mg/day as add-on therapy 7
Recent case reports demonstrate marked diuresis and resolution of refractory pulmonary edema within 72 hours when acetazolamide 500 mg IV daily is added to conventional therapy 8.
Metabolic Alkalosis
Acetazolamide treats chloride depletion alkalosis, particularly diuretic-induced cases, by increasing urinary bicarbonate excretion 9, 10. However, evidence quality varies, and optimal dosing remains uncertain 10.
Other Applications
Additional uses include 11, 9:
- Idiopathic intracranial hypertension (reduces CSF production)
- Post-hypercapnic metabolic alkalosis
- Ventilator weaning in COPD patients
- Prevention of high-dose methotrexate toxicity
Safety Profile
Common side effects are generally trivial and include 2:
- Paresthesias of hands and feet
- Altered taste
- Increased diuresis
- Hypokalemia (monitor electrolytes)
- Rarely: kidney stones
Critical precautions:
- Acetazolamide is a sulfonamide derivative—avoid in sulfa allergy
- Reduce dosing frequency to every 12 hours if creatinine clearance <50 mL/min 9
- When combined with other diuretics, carefully monitor for dehydration and electrolyte imbalances 4
- In heart failure patients at altitude, potential for acid-base disturbances and arrhythmias requires electrolyte monitoring 2
Dosing Summary by Indication
- Glaucoma/Epilepsy/Edema: Per FDA label, varies by condition 1
- CSA: 250-1,000 mg daily divided 2
- AMS prevention: 500-750 mg/day for rapid ascent >3,500 m 3; 250-500 mg/day for standard prophylaxis 5
- Heart failure (diuretic resistance): 250-500 mg/day 7, 8
Plasma half-life is 4-8 hours, though pharmacologic effects last longer 9. Extended-release formulations allow once-daily dosing, potentially improving adherence 5.